08:00 , Dec 3, 2007 |  BC Week In Review  |  Company News

Reliant, GlaxoSmithKline deal

GSK will acquire Reliant for $1.7 billion in cash. The acquisition gives GSK U.S. rights to Lovaza omega 3 acid ethyl esters, which is marketed for use as an adjunct to diet to treat hypertriglyceridemia....
08:00 , Dec 3, 2007 |  BioCentury  |  Finance

Ebb & Flow II

The $1.7 billion in cash that GlaxoSmithKline (LSE:GSK; GSK) paid for specialty pharma company Reliant is not providing a hefty return for some of the latter's long-term investors. Alkermes (ALKS), which owns 12.9% of Reliant,...
00:27 , Nov 22, 2007 |  BC Extra  |  Top Story

GSK acquiring Reliant for $1.7B

GlaxoSmithKline (LSE:GSK; GSK) said it will acquire cardiovascular company Reliant (Liberty Corner, N.J.) for $1.7 billion in cash. The acquisition gives GSK U.S. rights to Lovaza , which is marketed for use as an adjunct...
07:00 , Oct 29, 2007 |  BioCentury  |  Finance

Ebb & Flow

Biogen Idec (BIIB) was off last week on slowing sales of Avonex interferon beta-1a, eroding $3.50 to $76.72 for the week. On the company's conference call, President and CEO James Mullen said 3Q07 sales of...
01:48 , Oct 26, 2007 |  BC Extra  |  Financial News

Reliant amends IPO

Cardiovascular company Reliant (Liberty Corner, N.J.) amended its IPO and hopes to sell 10 million shares at $25-$27 in an offering underwritten by Goldman Sachs; Merrill Lynch; JPMorgan; Banc of America Securities; and Lazard. A...
00:41 , Aug 11, 2007 |  BC Extra  |  Financial News

Reliant refiles for IPO

Cardiovascular company Reliant (Liberty Corner, N.J.) refiled for an IPO and hopes to raise up to $400 million in an offering underwritten by Goldman Sachs; Merrill Lynch; JPMorgan; Bank of America Securities; and Lazard. The...
07:00 , Jul 31, 2006 |  BC Week In Review  |  Clinical News

Sigma-Aldrich preclinical data

Researchers published in Nature Medicine that stress in ovarian cancer cells promoted tumor growth and angiogenesis through activation of adrenergic receptor beta . Also, in a mouse model of ovarian cancer, stress significantly enhanced mean...
03:25 , Nov 18, 2005 |  BC Extra  |  Financial News

Reliant pulls IPO

Cardiovascular company Reliant (Liberty Corner, N.J.) withdrew its proposed IPO, citing market conditions. In May, Reliant filed to raise up to $300 million through Goldman Sachs; Banc of America Securities; Deutsche Bank; JPMorgan; William Blair;...
23:32 , May 20, 2005 |  BC Extra  |  Financial News

Reliant files for IPO

Cardiovascular company Reliant (Liberty Corner, N.J.) filed to raise up to $300 million in an IPO underwritten by Goldman Sachs; Banc of America Securities; Deutsche Bank; JPMorgan; William Blair; and Lazard. Reliant markets hypertension drugs...
08:00 , Mar 17, 2003 |  BC Week In Review  |  Clinical News

InnoPran XL propranolol once-daily beta blocker regulatory update

The FDA granted marketing approval for InnoPran XL to treat hypertension. The product uses Diffucaps delivery technology from Eurand B.V. (Milan, Italy). Reliant Pharmaceuticals LLC , Liberty Corner, N.J.   Product: InnoPran XL propranolol once-daily...